Implantable cardioverter-defibrillator in primary prevention should be endovascular lead

19 May 2025 (11:00 - 11:15)
Organised by: Logo
Congress Presentation Part of: Controversies about implantable cardioverter-defibrillator and cardiac resynchronisation therapy Device Therapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by